C4X Discovery

Manchester, United Kingdom Founded: 2008 • Age: 18 yrs
Developer of optimized drug discovery and design services

About C4X Discovery

C4X Discovery is a company based in Manchester (United Kingdom) founded in 2008.. The company has 46 employees as of June 30, 2021. C4X Discovery has completed 1 acquisition, including Adorial. C4X Discovery offers products and services including Conformetrix Platform and PatientSeek Platform. C4X Discovery operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Insitro, BridgeBio and ATAI, among others.

  • Headquarter Manchester, United Kingdom
  • Employees 46 as on 30 Jun, 2021
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name C4x Discovery Holdings Plc
  • Date of Incorporation 16 Jul, 2014
  • Jurisdiction MANCHESTER
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Healthcare → Pharmaceuticals & Therapeutics
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $7.65 M (USD)
    0
    as on Jul 31, 2021
  • Net Profit
    $-5.21 M (USD)
    51
    as on Jul 31, 2021
  • EBITDA
  • Latest Funding Round
    $11 M (USD), Post-IPO

    Jan 03, 2024

  • Investors
    Gov.uk

    & 6 more

  • Employee Count
    46

    as on Jun 30, 2021

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of C4X Discovery

C4X Discovery offers a comprehensive portfolio of products and services, including Conformetrix Platform and PatientSeek Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Enables rational drug design with 4D structural data for immuno-inflammatory treatments.

Provides genetics-led insights for patient response prediction in therapies.

People of C4X Discovery
Headcount 10-50
Employee Profiles 14
Board Members and Advisors 5
Employee Profiles
People
Simon Jones
Head Of IT
People
Brad Hoy
CFO
People
Clive Dix
CEO
People
Catherine Tralau-Stewart
Chief Scientific Officer

Unlock access to complete

Board Members and Advisors
people
Natalie Walter
Non-Executive Director
people
Alex Stevenson
Non-Executive Director
people
Simon Harford
Non-Executive Director, Board member
people
Mario Polywka
Non-Executive Director, Board member

Unlock access to complete

Funding Insights of C4X Discovery

  • Total Funding
  • Total Rounds 9
  • Last Round Post-IPO — $11.0M
  • First Round
  • Investors Count 7
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2024 Amount Post-IPO - C4X Discovery Valuation

investors

Aug, 2022 Amount Post-IPO - C4X Discovery Valuation

investors

Oct, 2020 Amount Post-IPO - C4X Discovery Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in C4X Discovery

C4X Discovery has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Gov.uk, Astrazeneca and Calculus Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Private equity investments are directed across multiple sectors.
Founded Year Domain Location
Adams Plc is focused on special situation investment opportunities.
Founded Year Domain Location
UK venture capital investments are managed by Calculus Capital.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by C4X Discovery

C4X Discovery has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Adorial. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Proprietary in silico genomics platform is utilized for drug discovery.
2014
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - C4X Discovery

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

C4x Discovery Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of C4X Discovery

C4X Discovery operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Insitro, BridgeBio and ATAI, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Novel biopharmaceutical medicines are developed for unmet medical needs.
domain founded_year HQ Location
Therapies for neurodegenerative and immunology disorders are developed.
domain founded_year HQ Location
An AI-enabled platform is developed for infectious disease treatment.
domain founded_year HQ Location
Therapeutics for genetic diseases are developed through targeted interventions.
domain founded_year HQ Location
A biopharmaceutical company accelerating innovative mental health treatments.
domain founded_year HQ Location
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on C4x Discovery

Frequently Asked Questions about C4X Discovery

When was C4X Discovery founded?

C4X Discovery was founded in 2008 and raised its 1st funding round 1 year after it was founded.

Where is C4X Discovery located?

C4X Discovery is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.

How many employees does C4X Discovery have?

As of Jun 30, 2021, the latest employee count at C4X Discovery is 46.

What is the annual revenue of C4X Discovery?

Annual revenue of C4X Discovery is $7.65M as on Jul 31, 2021.

What does C4X Discovery do?

Founded in 2008 and based in Manchester, United Kingdom, operations focus on the biotechnology sector through drug discovery and design. Proprietary software platforms, including Taxonomy3 for human genetics analysis and Conformetrix for determining 3D molecular shapes, are utilized alongside NMR technology for candidate optimization. A pipeline includes treatments for addiction, diabetes, inflammation, and oncology.

Who are the top competitors of C4X Discovery?

C4X Discovery's top competitors include Jazz Pharmaceuticals, BridgeBio and C4 Therapeutics.

What products or services does C4X Discovery offer?

C4X Discovery offers Conformetrix Platform and PatientSeek Platform.

How many acquisitions has C4X Discovery made?

C4X Discovery has made 1 acquisition, including Adorial.

Who are C4X Discovery's investors?

C4X Discovery has 7 investors. Key investors include Gov.uk, Astrazeneca, Calculus Capital, Polar Capital, and Panmure Gordon.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available